Drug maker Cipla on Friday reported a 57% year-on-year dip in consolidated profit after tax to ₹676 crore for the third quarter ended December 31, 2025, impacted by a drop in US sales.
Cipla Q3 Net Dips 57% YoY to ₹676 Cr
The Mumbai-based firm posted a profit after tax at ₹1,571 crore for the October-December quarter last year
Cipla Q3 Net Dips 57% YoY to ₹676 Cr
Advertisement
The Mumbai-based firm posted a profit after tax at ₹1,571 crore for the October-December quarter last year.
Total income from operations rose to ₹7,074 crore for the period under review as against ₹7,073 crore in the year-ago period, Cipla said in a regulatory filing.
The company's North America sales dropped 22% to ₹1,485 crore during the quarter as compared with ₹1,906 crore in the year-ago period.
Cipla shares were trading 3.76% down at ₹1,319.95 apiece on BSE.